Search | VHL Search Portal

1.

Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.

Scott, Jessica M; Lee, Jasme; Herndon, James E; Michalski, Meghan G; Lee, Catherine P; O'Brien, Kelly A; Sasso, John P; Yu, Anthony F; Rowed, Kylie A; Bromberg, Jacqueline F; Traina, Tiffany A; Gucalp, Ayca; Sanford, Rachel A; Gajria, Devika; Modi, Shanu; Comen, Elisabeth A; D'Andrea, Gabriella; Blinder, Victoria S; Eves, Neil D; Peppercorn, Jeffrey M; Moskowitz, Chaya S; Dang, Chau T; Jones, Lee W.

Eur Heart J ; 44(46): 4878-4889, 2023 Dec 07.

Article in English | MEDLINE | ID: mdl-36806405

2.

A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors.

Hudis, Clifford; Swanton, Charles; Janjigian, Yelena Y; Lee, Ray; Sutherland, Stephanie; Lehman, Robert; Chandarlapaty, Sarat; Hamilton, Nicola; Gajria, Devika; Knowles, James; Shah, Jigna; Shannon, Keith; Tetteh, Ernestina; Sullivan, Daniel M; Moreno, Carolina; Yan, Li; Han, Hyo Sook.

Breast Cancer Res ; 15(6): R110, 2013 Nov 19.

Article in English | MEDLINE | ID: mdl-24252402

3.

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.

Gajria, Devika; Gonzalez, Joseph; Feigin, Kimberly; Patil, Sujata; Chen, Carol; Theodoulou, Maria; Drullinsky, Pamela; D'Andrea, Gabriella; Lake, Diana; Norton, Larry; Hudis, Clifford A; Traina, Tiffany A.

Breast Cancer Res Treat ; 131(1): 111-6, 2012 Jan.

Article in English | MEDLINE | ID: mdl-21898114

4.

Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer.

Gajria, Devika; Feigin, Kim; Tan, Lee K; Patil, Sujata; Geneus, Stephanie; Theodoulou, Maria; Norton, Larry; Hudis, Clifford A; Traina, Tiffany A.

Cancer ; 117(18): 4125-31, 2011 Sep 15.

Article in English | MEDLINE | ID: mdl-21387266

5.

Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia.

Freites-Martinez, Azael; Chan, Donald; Sibaud, Vincent; Shapiro, Jerry; Fabbrocini, Gabriella; Tosti, Antonella; Cho, Juhee; Goldfarb, Shari; Modi, Shanu; Gajria, Devika; Norton, Larry; Paus, Ralf; Cigler, Tessa; Lacouture, Mario E.

JAMA Dermatol ; 155(6): 724-728, 2019 06 01.

Article in English | MEDLINE | ID: mdl-30840033

6.

Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.

Freites-Martinez, Azael; Shapiro, Jerry; Chan, Donald; Fornier, Monica; Modi, Shanu; Gajria, Devika; Dusza, Stephen; Goldfarb, Shari; Lacouture, Mario E.

JAMA Dermatol ; 154(6): 670-675, 2018 06 01.

Article in English | MEDLINE | ID: mdl-29641806

7.

The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma.

Soumerai, Jacob D; Zelenetz, Andrew D; Moskowitz, Craig H; Palomba, M Lia; Hamlin, Paul A; Noy, Ariela; Straus, David J; Moskowitz, Alison J; Younes, Anas; Matasar, Matthew J; Horwitz, Steven M; Portlock, Carol S; Konner, Jason A; Gounder, Mrinal M; Hyman, David M; Voss, Martin H; Fury, Matthew G; Gajria, Devika; Carvajal, Richard D; Ho, Alan L; Beumer, Jan H; Kiesel, Brian; Zhang, Zhigang; Chen, Alice; Little, Richard F; Jarjies, Christine; Dang, Thu O; France, Fallon; Mishra, Nishant; Gerecitano, John F.

Clin Cancer Res ; 23(15): 4119-4126, 2017 Aug 01.

Article in English | MEDLINE | ID: mdl-28314788

8.

Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review.

Cadoo, Karen A; Gajria, Devika; Suh, Emily; Patil, Sujata; Theodoulou, Maria; Norton, Larry; Hudis, Clifford A; Traina, Tiffany A.

NPJ Breast Cancer ; 2: 16006, 2016.

Article in English | MEDLINE | ID: mdl-28721374

9.

A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.

Iyengar, Neil M; Fornier, Monica N; Sugarman, Steven M; Theodoulou, Maria; Troso-Sandoval, Tiffany A; D'Andrea, Gabriella M; Drullinsky, Pamela R; Gajria, Devika; Goldfarb, Shari B; Comen, Elizabeth A; Lake, Diana E; Modi, Shanu; Traina, Tiffany A; Lacouture, Mario E; Chen, Melanie F; Patil, Sujata; Baselga, José; Norton, Larry; Hudis, Clifford A; Dang, Chau T.

Clin Breast Cancer ; 16(2): 87-94, 2016 Apr.

Article in English | MEDLINE | ID: mdl-26454612

10.

Caspase activation is required for gemcitabine activity in multiple myeloma cell lines.

Nabhan, Chadi; Gajria, Devika; Krett, Nancy L; Gandhi, Varsha; Ghias, Kulsoom; Rosen, Steven T.

Mol Cancer Ther ; 1(13): 1221-7, 2002 Nov.

Article in English | MEDLINE | ID: mdl-12479703

11.

Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Dang, Chau; Iyengar, Neil; Datko, Farrah; D'Andrea, Gabriella; Theodoulou, Maria; Dickler, Maura; Goldfarb, Shari; Lake, Diana; Fasano, Julie; Fornier, Monica; Gilewski, Theresa; Modi, Shanu; Gajria, Devika; Moynahan, Mary Ellen; Hamilton, Nicola; Patil, Sujata; Jochelson, Maxine; Norton, Larry; Baselga, Jose; Hudis, Clifford.

J Clin Oncol ; 33(5): 442-7, 2015 Feb 10.

Article in English | MEDLINE | ID: mdl-25547504

12.

High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).

Larson, Sarah M; Campbell, Nicholas P; Huo, Dezheng; Artz, Andrew; Zhang, Yanming; Gajria, Devika; Green, Margaret; Weiner, Howie; Daugherty, Christopher; Odenike, Olatoyosi; Godley, Lucy A; Hyjek, Elizabeth; Gurbuxani, Sandeep; Thirman, Michael; Sipkins, Dorothy; Van Besien, Koen; Larson, Richard A; Stock, Wendy.

Leuk Lymphoma ; 53(3): 445-50, 2012 Mar.

Article in English | MEDLINE | ID: mdl-21913806

13.

HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies.

Gajria, Devika; Chandarlapaty, Sarat.

Expert Rev Anticancer Ther ; 11(2): 263-75, 2011 Feb.

Article in English | MEDLINE | ID: mdl-21342044

14.

Adjuvant taxanes: more to the story.

Gajria, Devika; Seidman, Andrew; Dang, Chau.

Clin Breast Cancer ; 10 Suppl 2: S41-9, 2010 Sep.

Article in English | MEDLINE | ID: mdl-20805064

15.

Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.

Odenike, Olatoyosi M; Larson, Richard A; Gajria, Devika; Dolan, M Eileen; Delaney, Shannon M; Karrison, Theodore G; Ratain, Mark J; Stock, Wendy.

Invest New Drugs ; 26(3): 233-9, 2008 Jun.

Article in English | MEDLINE | ID: mdl-18217206

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: